(Reuters) – The U.S. FDA on Wednesday approved Actelion Pharmaceuticals’ injection, making it the first treatment for severe frostbite in adults to reduce the risk of finger or toe amputation.
(Reporting by Sriparna Roy in Bengaluru; Editing by Krishna Chandra Eluri)
